Table 3.
Metabolic syndrome assessment parameters.
| Parameter | Time | Control | F | F2 | FG | G |
|---|---|---|---|---|---|---|
| F glu mmol/L |
d0 | 3.8 ± 0.18 | 5.6 ± 0.25∗ | 5.5 ± 0.30∗ | 5.8 ± 0.22∗ | 3.7 ± 0.19 |
| d20 | 4.4 ± 0.18 | 5.9 ± 0.16∗ | 6.1 ± 0.23∗ | 6.7 ± 0.19∗ | 4.2 ± 0.18 | |
|
| ||||||
| Serum cholesterol mmol/L |
d0 | 0.87 ± 0.08 | 1.17 ± 0.05 | 1.18 ± 0.09 | 1.24 ± 0.09 | 0.84 ± 0.08 |
| d20 | 0.92 ± 0.07 | 1.19 ± 0.07 | 1.24 ± 0.06 | 1.37 ± 0.13∗ | 0.77 ± 0.09 | |
|
| ||||||
| Serum triglyceride mmol/L |
d0 | 0.65 ± 0.1 | 1.27 ± 0.15∗ | 1.30 ± 0.12∗ | 1.32 ± 0.11∗ | 0.84 ± 0.08 |
| d20 | 0.70 ± 0.13 | 1.24 ± 0.10∗ | 1.29 ± 0.14∗ | 1.67 ± 0.14∗ | 0.77 ± 0.09 | |
|
| ||||||
| Serum insulin μ I.U/mL |
d0 | 24.2 ± 1.9 | 23.3 ± 1.9 | 25.2 ± 1.7 | 25.2 ± 1.7 | 26.4 ± 1.9 |
| d20 | 26.2 ± 2.1 | 29.4 ± 2.3 | 31.3 ± 1.9∗ | 38.3 ± 1.9∗ | 24.1 ± 2.1 | |
|
| ||||||
| Obesity index | d20 | 2.04 ± 0.13 | 2.75 ± 0.22∗@ | 2.74 ± 0.21∗@ | 3.14 ± 0.21∗@ | 2 ± 0.16‡,#,$ |
Serum parameters measurements were taken on days 0 and 20 of gentamicin therapy which correspond to the 38th and the 58th days of the high fructose water treatment period. Obesity index was measured at the end of the treatment period. Results are expressed in mean ± SEM. ∗, ‡, #, $, and @ indicate statistical significance as compared to control, F, F2, FG, and G groups, respectively (P < 0.05).